BioPharm Editor in Chief, Laura Bush, Joins Interphex Conference Advisory Board
Laura Bush, editor in chief of BioPharm International, has joined the 2010 Interphex Conference Advisory Board.
Laura Bush, editor in chief of BioPharm International, has joined the 2010 Interphex Conference Advisory Board.
The board consists of pharmaceutical and biopharmaceutical manufacturers, suppliers, and industry experts. Board members are asked to represent the needs of the industry at large, and to recommend speakers as able.
BioPharm International has been a media partner at Interphex New York for the past several years. At Interphex 2009, BioPharm sponsored the keynote panel discussion, which was chaired by Laura Bush and featured several notable industry experts, including G. Steven Burrill, Tim Moore of Genentech, Divakar Ramakrishnan of Eli Lilly, and Michael D. Kowolenko of Wyeth.
Podcasts with speakers Tim Moore and Michael Kowolenko can be found at www.biopharminternational.com/InterphexKeynote.
A vidcast of the keynote can be found on the Interphex365 web site.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
